|
DHX29 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.33066907387547E-16 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.11022302462516E-16 |
| Normal-vs-Stage2 |
2.62899999992072E-07 |
| Normal-vs-Stage3 |
5.28850000014458E-07 |
| Normal-vs-Stage4 |
3.0936997408304E-10 |
| Stage1-vs-Stage2 |
8.504600E-01 |
| Stage1-vs-Stage3 |
5.835800E-01 |
| Stage1-vs-Stage4 |
2.753200E-01 |
| Stage2-vs-Stage3 |
5.815400E-01 |
| Stage2-vs-Stage4 |
3.535600E-01 |
| Stage3-vs-Stage4 |
1.947000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
1.58310031750375E-11 |
| Normal-vs-Asian |
6.699500E-02 |
| Caucasian-vs-AfricanAmerican |
4.318000E-01 |
| Caucasian-vs-Asian |
4.468200E-01 |
| AfricanAmerican-vs-Asian |
6.624800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
2.61350000529958E-08 |
| Male-vs-Female |
1.575290E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.61051205494323E-12 |
| Normal-vs-Extreme_Weight |
<1E-12 |
| Normal-vs-Obese |
1.02928776612998E-12 |
| Normal-vs-Extreme_Obese |
2.048000E-04 |
| Normal_Weight-vs-Extreme_Weight |
8.722400E-01 |
| Normal_Weight-vs-Obese |
4.087800E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.106800E-01 |
| Extreme_Weight-vs-Obese |
2.391800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.653200E-01 |
| Obese-vs-Extreme_Obese |
4.576600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.22059999885238E-08 |
| Normal-vs-Age(41-60Yrs) |
2.48689957516035E-14 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
4.03380000513209E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.539200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.753800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.965400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.249790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.802600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.989800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
<1E-12 |
| Normal-VS-Type2 PRCC |
6.75900446722721E-11 |
| Normal-VS-KIRP CIMP |
2.26296759109346E-12 |
| Normal-VS-Unclassified PRCC |
1.22820000003632E-06 |
| Type1 PRCC-VS-Type2 PRCC |
4.522400E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.236600E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.561600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
8.37670000000124E-05 |
| Type2 PRCC-VS-Unclassified PRCC |
8.996600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.758790E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.76803016671556E-12 |
| Normal-vs-N1 |
1.79806999999199E-05 |
| Normal-vs-N2 |
2.47160000022006E-07 |
| N0-vs-N1 |
4.039400E-01 |
| N0-vs-N2 |
3.274200E-01 |
| N1-vs-N2 |
2.463600E-01 |
|
|
